Yelin Lapidot group discloses 5.95% MediWound (MDWD) holding in amended 13G

Rhea-AI Filing Summary

MediWound Ltd. investor Yelin Lapidot group reports a 5.95% passive stake in the company’s ordinary shares. Amendment No. 1 to Schedule 13G shows Yelin Lapidot Holdings Management Ltd., together with Dov Yelin and Yair Lapidot, beneficially owning 763,069 ordinary shares with shared voting and dispositive power.

The stake is held through mutual and provident funds managed by wholly owned subsidiaries of Yelin Lapidot Holdings, for the benefit of fund members. The reporting persons expressly state the securities were not acquired and are not held to change or influence control of MediWound.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/05/2026 - 08:04 AM Learn about SEC filing dates

FAQ

What ownership stake in MediWound Ltd. (MDWD) is reported in this Schedule 13G/A?

The filing reports beneficial ownership of 763,069 MediWound ordinary shares, representing 5.95% of the outstanding class. This percentage is based on 12,821,433 ordinary shares outstanding as of December 31, 2025, as referenced in the document.

Who are the reporting persons in the MediWound Ltd. (MDWD) Schedule 13G/A?

The reporting persons are Yelin Lapidot Holdings Management Ltd., Dov Yelin, and Yair Lapidot. All are organized or are citizens of Israel and jointly report beneficial ownership of MediWound ordinary shares through managed mutual and provident funds.

How is the MediWound Ltd. (MDWD) 5.95% stake held according to the filing?

The stake is held through mutual funds and provident funds managed by wholly owned subsidiaries of Yelin Lapidot Holdings. These subsidiaries operate under independent management, and the economic interest is for the benefit of the funds’ members, not the reporting individuals personally.

Does the MediWound Ltd. (MDWD) Schedule 13G/A indicate an attempt to influence control?

The certification states the securities were not acquired and are not held to change or influence control of MediWound. They are not held in connection with any transaction having that purpose or effect, except for activities related to a nomination under Rule 240.14a-11.

How are the MediWound Ltd. (MDWD) shares split between Yelin Lapidot-managed funds?

As of December 31, 2025, 328,985 ordinary shares (2.57%) are beneficially owned by mutual funds managed by Yelin Lapidot Mutual Funds Management Ltd., and 434,084 ordinary shares (3.39%) by provident funds managed by Yelin Lapidot Provident Funds Management Ltd.

Do Dov Yelin and Yair Lapidot claim personal beneficial ownership of MDWD shares?

The statement specifies it shall not be construed as an admission that Dov Yelin, Yair Lapidot, Yelin Lapidot Holdings, or its subsidiaries are beneficial owners of the securities. Each expressly disclaims beneficial ownership of the MediWound shares covered.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

MediWound Ltd.

(Name of Issuer)

Ordinary shares, par value NIS 0.07 per share

(Title of Class of Securities)

M68830112

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. M68830112

1

Names of Reporting Persons

Yelin Lapidot Holdings Management Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ISRAEL

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 763,069.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 763,069.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

763,069.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.95 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: With regard to rows (6), (8), (9) and (11), the beneficial ownership of the securities reported herein is described in Item 4(a). Row (11) is Based on 12,821,433 Ordinary Shares outstanding as of December 31, 2025 (as reported on Bloomberg LP).

SCHEDULE 13G

CUSIP No. M68830112

1

Names of Reporting Persons

Dov Yelin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ISRAEL

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 763,069.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 763,069.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

763,069.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.95 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: With regard to rows (6), (8), (9) and (11), the beneficial ownership of the securities reported herein is described in Item 4(a). Row (11) is Based on 12,821,433 Ordinary Shares outstanding as of December 31, 2025 (as reported on Bloomberg LP).

SCHEDULE 13G

CUSIP No. M68830112

1

Names of Reporting Persons

Yair Lapidot

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ISRAEL

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 763,069.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 763,069.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

763,069.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.95 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: With regard to rows (6), (8), (9) and (11), the beneficial ownership of the securities reported herein is described in Item 4(a). Row (11) is Based on 12,821,433 Ordinary Shares outstanding as of December 31, 2025 (as reported on Bloomberg LP).

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MediWound Ltd.
(b)	Address of issuer's principal executive offices: 42 Hayarkon Street, Yavne, L3, 8122745
Item 2.
(a)	Name of person filing: Yelin Lapidot Holdings Management Ltd. Dov Yelin Yair Lapidot
(b)	Address or principal business office or, if none, residence: Yelin Lapidot Holdings Management Ltd. - 50 Dizengoff St., Dizengoff Center, Gate 3, Top Tower, 13th floor, Tel Aviv 64332, Israel Dov Yelin - 50 Dizengoff St., Dizengoff Center, Gate 3, Top Tower, 13th floor, Tel Aviv 64332, Israel Yair Lapidot - 50 Dizengoff St., Dizengoff Center, Gate 3, Top Tower, 13th floor, Tel Aviv 64332, Israel
(c)	Citizenship: Yelin Lapidot Holdings Management Ltd. - Israel Dov Yelin - Israel Yair Lapidot - Israel
(d)	Title of class of securities: Ordinary shares, par value NIS 0.07 per share
(e)	CUSIP No.: M68830112
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See row 9 of cover page of each reporting person. On December 31, 2025, the securities reported herein were beneficially owned as follows: 328,985 Ordinary Shares (representing 2.57% of the total Ordinary Shares outstanding) beneficially owned by mutual funds managed by Yelin Lapidot Mutual Funds Management Ltd. 434,084 Ordinary Shares (representing 3.39% of the total Ordinary Shares outstanding) beneficially owned by provident funds managed by Yelin Lapidot Provident Funds Management Ltd. The securities reported herein are beneficially owned by provident funds managed by Yelin Lapidot Provident Funds Management Ltd. and/or mutual funds managed by Yelin Lapidot Mutual Funds Management Ltd. (the "Subsidiaries"), each a wholly-owned subsidiary of Yelin Lapidot Holdings Management Ltd. ("Yelin Lapidot Holdings"). Mr. Yelin owns 24.38% of the share capital and 25.00% of the voting rights of Yelin Lapidot Holdings, Mr. Lapidot owns 24.62% of the share capital and 25.00% of the voting rights of Yelin Lapidot Holdings. Messrs Yelin and Lapidot are responsible for the day-to-day management of Yelin Lapidot Holdings. In accordance with the Shareholders' Agreement, dated December 5, 2018, until the End of the "Suspension Period" Messrs Yelin and Lapidot are entitled to jointly appoint the majority of the members of Yelin Lapidot Holdings board. The Subsidiaries operate under independent management and make their own independent voting and investment decisions. Any economic interest or beneficial ownership in any of the securities covered by this report is held for the benefit of the members of the provident funds or mutual funds, as the case may be. This Statement shall not be construed as an admission by Messrs. Yelin and Lapidot, Yelin Lapidot Holdings or the Subsidiaries that he or it is the beneficial owner of any of the securities covered by this Statement, and each of Messrs. Yelin and Lapidot, Yelin Lapidot Holdings, and the Subsidiaries disclaims beneficial ownership of any such securities.
(b)	Percent of class: See row 11 of cover page of each reporting person
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See row 5 of cover page of each reporting person
	(ii) Shared power to vote or to direct the vote: See row 6 of cover page of each reporting person and note in Item 4(a) above
	(iii) Sole power to dispose or to direct the disposition of: See row 7 of cover page of each reporting person
	(iv) Shared power to dispose or to direct the disposition of: See row 8 of cover page of each reporting person and note in Item 4(a) above
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Yelin Lapidot Holdings Management Ltd.

Signature:	/s/ Dov Yelin
Name/Title:	Dov Yelin / Joint Chief Executive Officer
Date:	01/29/2026

Dov Yelin

Signature:	/s/ Dov Yelin
Name/Title:	Dov Yelin
Date:	01/29/2026

Yair Lapidot

Signature:	/s/ Yair Lapidot
Name/Title:	Yair Lapidot
Date:	01/29/2026

Exhibit Information

Exhibit 1 - Joint Filing Agreement filed by and among the Reporting Persons, dated as of October 1, 2024 (incorporated herein by reference to Exhibit 1 to the Schedule 13G filed on October 1, 2024).